Utama › Kanser Paru-paru Bukan Sel Kecil › Ohio › Toledo
Kajian klinikal Kanser Paru-paru Bukan Sel Kecil di Toledo, OH
17 kajian untuk Kanser Paru-paru Bukan Sel Kecil sedang mencari peserta di lokasi dalam dan sekitar Toledo (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Mengambil pesertaFasa 2
- Mercy Health - Perrysburg Cancer Center /ID# 270536, Perrysburg · 8 mi jauh
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
Mengambil pesertaFasa 3
- ProMedica Flower Hospital, Sylvania · 9 mi jauh
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Mengambil pesertaFasa 3
- Mercy Health - Saint Anne Hospital, Toledo
- Mercy Health - Perrysburg Hospital, Perrysburg · 8 mi jauh
- ProMedica Flower Hospital, Sylvania · 9 mi jauh
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
Mengambil pesertaFasa 1
- Site 06, Maumee · 9 mi jauh
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Mengambil pesertaFasa 3
- Taylor Cancer Research Center, Maumee · 9 mi jauh
Pan-tumor MRD Study
Mengambil pesertaKajian pemerhatian
- Taylor Cancer Research Center, Maumee · 9 mi jauh
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Mengambil pesertaFasa 3
- Research Site, Toledo
- Research Site, Maumee · 9 mi jauh
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Mengambil pesertaKajian pemerhatian
- Toledo Clinic Cancer Center, Toledo
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Mengambil pesertaFasa 2
- Mercy Health - Saint Anne Hospital, Toledo
- Mercy Health - Perrysburg Hospital, Perrysburg · 8 mi jauh
- ProMedica Flower Hospital, Sylvania · 9 mi jauh
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Mengambil pesertaFasa 1/2
- Taylor Cancer Research Center, Maumee · 9 mi jauh
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Mengambil pesertaFasa 3
- Research Site, Maumee · 9 mi jauh
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Mengambil pesertaFasa 2
- ProMedica Flower Hospital, Sylvania · 9 mi jauh
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Mengambil pesertaFasa 2/3
- ProMedica Flower Hospital, Sylvania · 9 mi jauh
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Mengambil pesertaFasa 2
- ProMedica Flower Hospital, Sylvania · 9 mi jauh
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
- Taylor Cancer Research Center, Maumee · 9 mi jauh
GEMINI-NSCLC: NSCLC Biomarker Study
Mengambil pesertaKajian pemerhatian
- Taylor Cancer Research Center, Maumee · 9 mi jauh
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Mengambil pesertaFasa 1/2
- Taylor Cancer Research Center (site 204), Maumee · 9 mi jauh
Kajian Kanser Paru-paru Bukan Sel Kecil di bandar lain
- Houston, TX145 kajian
- New York City, NY121 kajian
- Arlington, VA104 kajian
- Nashville, TN97 kajian
- Boston, MA90 kajian
- Los Angeles, CA87 kajian
- St. Louis, MO73 kajian
- Chicago, IL61 kajian
- Baltimore, MD60 kajian
- San Antonio, TX59 kajian
- Columbus, OH57 kajian
- Washington, DC55 kajian
Kajian lain di Toledo
- Kanser Ovari12 kajian
- Kanser Paru-paru11 kajian
- Kanser Metastatik10 kajian
- Strok9 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher8 kajian
- Kanser Endometrium8 kajian
- Melanoma8 kajian
- Kanser Pankreas8 kajian
- Kanser Prostat7 kajian
- Kanser Esofagus7 kajian
- Stroke Iskemia7 kajian
- Kegagalan Jantung7 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.